XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 32.13

-0.5%

Nov 28 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: William L. Molair II who wrote (6336)	5/20/1998 11:18:00 PM
From: aknahow	Read Replies (1) of 17367

Heard the meeting went well. Clinical meningo trial explained and will end in mid dec. Xoma will file in Europe for new drug. based on these trials. Always possible that trial may be halted by DSMB or modified to permit placebo group to receive attention. Xoma indicated they would need 5 people for marketing/sales of Neuprex if this indication if approved. Hope I got this right.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next